In breast cancer studies, coexpression of PFKFB3 and PFKFB4 was significantly associated with metastasis and chemotherapy resistance, suggesting that they may drive tumor progression through shared signalling pathways (such as the PI3K/AKT pathway). This evidence concerns the gene PFKFB4 and neoplasm.